chr3-40182310-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The ENST00000302541.11(MYRIP):āc.964C>Gā(p.Gln322Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000616 in 1,461,726 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
ENST00000302541.11 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MYRIP | NM_015460.4 | c.964C>G | p.Gln322Glu | missense_variant | 9/17 | ENST00000302541.11 | NP_056275.2 | |
EIF1B-AS1 | NR_033965.1 | n.537-7588G>C | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYRIP | ENST00000302541.11 | c.964C>G | p.Gln322Glu | missense_variant | 9/17 | 1 | NM_015460.4 | ENSP00000301972 | P1 | |
EIF1B-AS1 | ENST00000657703.1 | n.91-64574G>C | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000796 AC: 2AN: 251150Hom.: 0 AF XY: 0.00000737 AC XY: 1AN XY: 135738
GnomAD4 exome AF: 0.00000616 AC: 9AN: 1461726Hom.: 1 Cov.: 30 AF XY: 0.00000413 AC XY: 3AN XY: 727162
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 25, 2023 | The c.964C>G (p.Q322E) alteration is located in exon 9 (coding exon 8) of the MYRIP gene. This alteration results from a C to G substitution at nucleotide position 964, causing the glutamine (Q) at amino acid position 322 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at